A potential therapy for blinding retinal diseases
National Institutes of Health (NIH) - 03-Nov-2020Researchers engineer novel protein that restores vision in blind mice via gene therapy
Join the club for FREE to access the whole archive and other member benefits.
Senior Technical Officer at Nanoscope Technologies
His current research activity span across the area of Optogenetics, Electrophysiology and Biomedical Instrumentation. He earned his PhD in Chemistry in 2014 where he primarily used ultrafast laser spectroscopy to investigate biomolecular interaction. Before joining Nanoscope Technologies, he was a Postdoctoral Research Associate at University of Texas at Arlington.His research achievements include the development of
1. Highly sensitive opsin for optogenetics vision restoration for treatment retinal disorders
2. Non invasive targeted Gene delivery by use of infrared laser
3. Label free optical techniques to detect neuronal activity.
He is passionate about scientific research especially in applied biomedical and clinical research, with a strong scientific, technical, experimental and interpersonal skills.
Visit website: https://www.nanoscopetech.com/our-team
See also: Nanoscope Technologies - Research and innovation in the area of vision restoration, cancer diagnosis, non-invasive pain management
Details last updated 04-Nov-2020
Researchers engineer novel protein that restores vision in blind mice via gene therapy